Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open, Randomised, Controlled, Parallel Group, Phase III Study to Investigate the Safety and Efficacy of Fermagate and Sevelamer Hydrochloride in Haemodialysis Patients With Hyperphosphataemia

NCT00844662 is registered in ClinicalTrials.gov with Ineos Healthcare Limited as lead sponsor.

NCT NCT00844662
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00844662 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open, Randomised, Controlled, Parallel Group, Phase III Study to Investigate the Safety and Efficacy of Fermagate and Sevelamer Hydrochloride in Haemodialysis Patients With Hyperphosphataemia
Lead sponsor
Ineos Healthcare Limited
Phase
Phase 3
Overall status
Terminated
Start date
July 31, 2009
Completion date
October 31, 2011
Enrollment
1,000 (estimated)
Sites
109

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney failure